DAVA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Endava plc Securities Lawsuit - Contact Levi & Korsinsky
Notice to Pension Funds, Asset Managers, and Fiduciaries: The lawsuit alleges Endava reported effective internal controls while its accounting for certain customer and supplier agreements required additional review.
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies pension funds, asset managers, and other institutional investors in Endava plc (NYSE: DAVA) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between September 4, 2025 and September 21, 2026. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
Endava's American Depositary Shares lost $0.68 apiece, or 24.37%, in the trading session after the Company's September 21, 2026 announcement, on unusually heavy volume. For fiduciaries weighing institutional investor securities recovery, including ERISA plan administrators, that single session cut nearly a quarter from the value of positions held at the prior close. The window to apply for lead plaintiff closes on November 30, 2026.
Institutional Investor Securities Recovery and ERISA Considerations
The pleading asserts that Endava's fiscal 2025 Form 20-F described internal control over financial reporting as effective as of June 30, 2025. As averred, investors were not told that the accounting for certain customer and supplier agreements required additional review, that fourth quarter and full year 2026 results would be delayed, or that there was reason to doubt those controls.
On September 21, 2026, Endava announced that its Chief Financial Officer had been placed on administrative leave pending an Audit Committee investigation, which the complaint describes as prompted by concerns the Company's outside auditors raised about that accounting treatment. The securities action alleges that the Company's positive statements about its business and prospects lacked a reasonable basis throughout the Class Period.
Fiduciary Obligations and Recovery Options
- Trustees and investment committees overseeing pension, endowment, or ERISA-governed assets that acquired DAVA ADSs during the Class Period may wish to confirm trade records with their custodians.
- Courts generally look to the movant with the largest financial interest in the relief sought, a factor that often favors institutional holders.
- A court-appointed lead plaintiff oversees litigation strategy and settlement discussions for the entire class and selects counsel, subject to court approval.
- Institutions that do not seek appointment generally remain absent class members and may still participate in any potential recovery.
- Because Endava is incorporated in England and Wales with ADSs listed on the NYSE, non-U.S. funds that bought on the U.S. market may fall within the proposed class.
"Institutional investors play a critical role in securities class actions, and fiduciaries holding Endava positions have a meaningful decision in front of them. The complaint alleges that shareholders received assurances of effective internal controls while the accounting for certain customer and supplier agreements allegedly required further review. Measuring those allegations against actual trading records is a prudent first step for any fiduciary." -- Joseph E. Levi, Esq.
Contact us to learn more about institutional recovery options or call (212) 363-7500.
INSTITUTIONAL INVESTOR REPRESENTATION — Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.
Frequently Asked Questions About the DAVA Lawsuit
Q: When did Endava plc allegedly mislead investors? A: The Class Period runs from September 4, 2025 to September 21, 2026. The complaint alleges that corrective disclosures revealed information that caused a significant stock decline.
Q: What court was the DAVA class action filed in? A: The case was filed in the United States District Court for the Southern District of New York, governed by the Private Securities Litigation Reform Act of 1995.
Q: Who are the defendants named in the DAVA lawsuit? A: The complaint names Endava plc and individual defendants including senior executives who signed SEC filings, made public statements, or certified financial disclosures under Sarbanes-Oxley.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor's country of residence.
Q: What if I already sold my DAVA shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
